期刊文献+

白血病细胞株KG1中Mxi1突变基因真核表达载体的构建

Construct Mxi1 Mutation Gene Expression Vector from Leukemia Cell Line KG1
原文传递
导出
摘要 目的构建Max结合蛋白1(Max interacting protein 1,Mxi1)基因的野生型和突变型真核表达载体,观察表达载体转染真核细胞后蛋白表达的情况。方法将正常人和白血病细胞株KG1细胞的Mxi1野生型/突变型基因cDNA插入到红色荧光蛋白质粒pDs-red2-N1中,构建为pDs-red2-N1/Mxi1(野生型/突变型)真核表达载体;采用脂质体方法将质粒转染Cos-7细胞;荧光显微镜观察Cos-7细胞红色荧光蛋白表达情况。流式细胞仪方法检测红色荧光蛋白中Mix1的基因表达率,以此计算转染效率。转染后48h提取细胞总RNA,进行RT-PCR检测Mxi1基因表达。结果成功构建了一种pDs-red2-N1/Mxi1(野生型/突变型)真核表达载体。荧光显微镜下观察转染后Cos-7细胞可见红色荧光蛋白的表达;流式细胞仪检测野生型和突变型的转染效率以转染后前3d较高,并可持续至第6d。质粒转染Cos-7细胞后均出现阳性Mxi1基因转录产物。RT-PCR方法可以检测到Mxi1基因在Cos-7细胞中的表达。结论 Mxi1的真核表达载体构建成功,通过脂质体的方法转染真核细胞中并在其胞浆中表达。 Objective To construct the eukaryotic expression vector for Max interacting protein 1(Mxi1).Methods The full length cDNA of Mxi1 gene obtained from fetal lymphocyte and KG1 cells were inserted into plasmid pDs-red2-N1 respectively to generate pDs-red2-N1/Mxi1(wild/mutation type).Then the recombinant vector was transfected into Cos-7 cells via liposome.48 hours post transfection,mRNA of Mxi1 gene was detected by RT-PCR and Mxi1 protein expression was detected by flow cytometry and fluorescence microscope in the Cos-7 cells.Results The eukaryotic expression vector of Mxi1 was constructed and transfected into eukaryotic cells successfully.The expression of red fluorescence protein in the transfected Cos-7 cells was observed under fluorescence microscope which implied the expression of Mxi1.The transfect efficiency of both wild and mutation type were in a high level in 3 days after transfected,which lasted to 6 d.RT-PCR amplified the total RNA extracted from the transfected Cos-7 cells could find increased mRNA level of Mxi1 gene.Conclusion We successfully constructed the eukaryote expression vector for Mxi1 gene;Cos-7 cells transfected with the vector via liposome could express Mxi1 protein.These could be useful for the further study of the Myc gene modulation.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2012年第4期498-502,共5页 Journal of Sichuan University(Medical Sciences)
基金 河北省自然科学基金(No.C2008001097) 河北省医学科学研究指令性计划(No.20090073)资助
关键词 Max结合蛋白1 髓细胞增生癌基因 载体构建 基因转染 Max interacting protein 1 Myelocytomatosis oncogene Gene mutation Vector construction
  • 相关文献

参考文献8

  • 1Zada AA, Pulikkan J A, Bararia D,et al. Proteomie discovery of Max as a novel interacting partner of C/EBP:a Myc/Ma.z:/Mad link. Leukemia,2006 ;20(12) :2137-2146.
  • 2Gallant P. Myc/Max/Mad in invertebrates:the evolution of the Max network. Curr Top Microbiol Immunol, 2006; 302: 235- 253.
  • 3Manni I, Tunici P, Cirenei N, et al. Mxil inhibits the proliferation of U87 glioma cells through down regulation of eyelin B1 gene expression. Brit J Cancer,2002;86(3):477-484.
  • 4Wong WJ, Simon MC. The role of MXI1 in VHL deficient tumorigenesis. Cancer Biol Ther,2008; (10) : 1628-1629.
  • 5Delpueeh O, Griffiths B, East P,etal. Induction of Mxil-SR by FOXO3a contributes to repression of Myc-dependent gene expression. Mol Cell Bio,2007;27(13) :4917 4930.
  • 6Guo XL, Pan L, Zhang XJ, et al. Expression and mutation analysis of genes that encode the Myc antagonists Madl, Mxil and Rox in acute leukaemia. Leuk Lymphoma, 2007;48(6): 1200-1207.
  • 7索晓慧,潘崚,姚丽,张学军,牛志云,董作仁.myc拮抗基因Mad1、Mxi1和Rox在白血病细胞中的表达和突变[J].中华血液学杂志,2007,28(11):745-749. 被引量:2
  • 8王逸群,朱平,石永进,顾江英,卜定方,刘辉,张英.遗传性铁粒幼细胞贫血致病的ALAS2基因表达载体的构建[J].中国实验血液学杂志,2004,12(5):687-693. 被引量:2

二级参考文献31

  • 1Cotter PD, May A, Li L, et al. Four new mutation in the erythroid-Specific 5-aminolevulinate synthase (ALAS2) gene causing X-linked sideroblastic anemia: increased pyridoxine responsiveness after removal of iron overload by phlebotomy and coinheritance of
  • 2Qaesnel B, Prendhomme C, Lepellev P, et al. Transfer of p16inka/CDKN2 gene in leukaemic cell lines inhibits cell proliferation: Br J Haematol, 1996; 95:291-298
  • 3May A, Bishop DF. The molecular biology and pyridoxine responsiveness of X-linked sideroblastic anemia: Haematologica 1998 Jan;83: 56 - 70
  • 4Gonzalez MI, Caballero D, Vazquez L, et al. Allogeneic peripheral stem cell transplantation in a case of hereditary sideroblastie anaemia: Br. J. Haematol. 2000; 109:658-660
  • 5Urban C, Binder B, Hauer C, et al. Congenital sideroblastic anemia successfully treated by allogeneic bone marrow transplantation: Bone Marrow Transplant, 1992; 10:373-375
  • 6Ayas M, Al-Jefri A, Mustafa MM, et al. Congenital sideroblastic anaemia successfully treated using allogeneic stem cell transplantation: Br J Haematol, 2002; 113: 938 - 939
  • 7Marshall E. Gene therapy death prompts review of adenovirus vector. Science, 1999; 286: 2244- 2245
  • 8Snyder RO, Miao C, Meuse L, et al. Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Na Med, 1999; 5:64-70
  • 9Cavazzana-Calvo M, hacein-Bey S, de-Saint Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 Disease. Science, 2000; 288:669-672
  • 10Marshall E. Clinical research. Gene therapy a suspect in leukemialike disease. Science, 2002; 298:34-35

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部